Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05509114
Other study ID # Rumeysa
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 25, 2021
Est. completion date July 27, 2022

Study information

Verified date August 2022
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study was conducted in a randomized controlled manner to determine the effect of applying virtual reality glasses during transrectal prostate biopsy on pain, anxiety and patient satisfaction.The study was completed with a total of 70 patients, 35 in the intervention group and 35 in the control group, for whom it was decided to perform sample transrectal prostate biopsy for the first time.


Description:

Although prostate cancer is the most common type of cancer in men, according to 2018 data published by the International Agency for Research on Cancer, it is the second most common after lung cancer worldwide.The prevalence of prostate cancer is increasing rapidly worldwide. However, when prostate cancer is diagnosed early, the survival rate increases with the effect of the treatment methods applied. Digital rectal examination (DRE), prostate specific antigen (PSA) level, and transrectal ultrasonography-guided prostate biopsy (TRUS-Bx) methods are used for diagnosis. Transrectal prostate biopsy process; It is one of the most frequently performed urological procedures for definitive diagnosis in patients with a PSA value above the normal limit and abnormal DRE findings. Transrectal prostate biopsy is a golden diagnostic tool in prostate cancer because it is typically well tolerated, treatable, and has a low risk of major complications. However, in addition to the advantages of this procedure, it also has disadvantages such as causing pain and discomfort in patients.Prostate biopsy procedure affects patients not only physiologically but also psychologically. Interventional procedures cause patients to experience the highest level of anxiety. With the development of technology, developments in health care have brought the concept of patient satisfaction to the fore. Applications made in line with patient expectations in order to increase the quality of care make a significant contribution to the perception of nursing care. One of these applications, virtual reality glasses, make patients feel like they are in a different world; increases patient satisfaction. Nurses, who are members of the profession who plan and manage care, because they spend longer time with the patient; They play an active role in defining pain and anxiety by using pharmacological and non-pharmacological methods. When examining the literature, there was no study examining the effect of virtual reality application on the pain level of patients during the transrectal prostate biopsy procedure, but no study examining the effect on the level of anxiety and patient satisfaction. In this study; It is aimed to increase patient satisfaction by reducing the pain and anxiety of the patients with virtual reality applied during the transrectal prostate biopsy procedure. It is thought that the results of this study can make an important contribution to both the literature and practice.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date July 27, 2022
Est. primary completion date June 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Those between the ages of 18-65, - Those who volunteer and accept to participate in the research, - Transrectal prostate biopsy procedure performed for the first time, - No communication problem, - Cognitive level scales are suitable for application, - Patients without vision or hearing problems were included in the study. Exclusion Criteria: - Leaving work voluntarily, - Patients whose cognitive level scales were not suitable for application were excluded from the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Virtual Reality Glasses
The intervention group of patients watched a video with virtual reality glasses during the transrectal biopsy process.

Locations

Country Name City State
Turkey Rumeysa Lale TORAMAN Palandöken Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary State-Trait Anxiety Inventory (STAI-I, STAI-II) It is a test developed by Spielberger et al. that measures state and trait anxiety levels. Its validity and reliability in Turkey was done by O¨ner and Le Compte. The scale consists of two parts, the 'state anxiety scale', which is created with the aim of determining the instantaneous feelings, and the 20-item 'trait anxiety scale', which was created to determine the feelings in general. It is a four degree scale ranging from 'Nothing' to 'All'. Scores range from 20 (low anxiety) to 80 (high anxiety). up to 24 hours
Primary The Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN) The patient's perception of nursing care scale was developed by Dozier et al. in the USA, and its Turkish validity and reliability were determined by Çoban and Kasikçi.Likert-type scale has 15 statements about the quality of nursing care. A minimum of 15 and a maximum of 75 points can be obtained from the scale. The cut-off point of the scale is 45. Scores above the cut-off point indicate a positive attitude. The increase in the total score obtained from the scale indicates that the patient is satisfied with the nursing care. up to 24 hours
Primary Visual Analog Scale for Pain (VAS) VAS is a scale developed by Price et al34 (1983) and measures the severity of pain in the patient. VAS is a 10 cm long vertical or horizontal scale with two different names (0=no pain, 10=most severe pain). An increase in the score obtained from the scale in the evaluation indicates an increase in pain. up to 24 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03197896 - Educational Intervention in Increasing Knowledge About Prostate Cancer in High-Risk Neighborhoods N/A
Completed NCT00026689 - Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Completed NCT00547625 - Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems Phase 2
Completed NCT00648323 - Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement Phase 4
Completed NCT00579423 - Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer Phase 2
Completed NCT00342433 - Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study
Not yet recruiting NCT06364865 - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
Active, not recruiting NCT03047135 - Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis Phase 2
Terminated NCT03197948 - Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
Completed NCT00586898 - Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle Phase 2
Recruiting NCT04518072 - Synthetic Metabolic and Genetic Networks for Medical Diagnosics
Completed NCT01118260 - Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection Phase 4
Recruiting NCT00923221 - Collection of Blood From Patients With Prostate Cancer
Active, not recruiting NCT01078662 - Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Phase 2
Completed NCT00423254 - Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. Phase 1
Terminated NCT02918227 - Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia N/A
Completed NCT02756975 - Prostate Core Needle Biopsy N/A
Active, not recruiting NCT00572468 - Statin Therapy Versus Placebo Prior to Prostatectomy N/A
Completed NCT00364455 - Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. Phase 3
Terminated NCT03318367 - Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy N/A